Renal glucosuria due to SGLT2 mutations
- PMID: 15110322
- DOI: 10.1016/j.ymgme.2004.01.018
Renal glucosuria due to SGLT2 mutations
Abstract
Isolated renal glucosuria results from mutations in SGLT2, which codes for an active transporter specific for d-glucose and expressed in the luminal membrane of the renal proximal tubule. In affected individuals, glucosuria leads to pursuit of hyperglycemia to exclude defects in glucose metabolism, and to investigation of renal proximal tubular function to exclude renal Fanconi syndrome. Here we present clinical and molecular data regarding a 19-year-old woman with isolated glucosuria. She was compound heterozygous for two SGLT2 mutations, i.e., a new missense mutation, T200K, and a known missense mutation, N654S.
Similar articles
-
Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2).Hum Genet. 2002 Dec;111(6):544-7. doi: 10.1007/s00439-002-0820-5. Epub 2002 Sep 27. Hum Genet. 2002. PMID: 12436245
-
A novel SGLT2 mutation in a patient with autosomal recessive renal glucosuria.Nephrol Dial Transplant. 2004 Nov;19(11):2893-5. doi: 10.1093/ndt/gfh426. Nephrol Dial Transplant. 2004. PMID: 15496564 No abstract available.
-
[Renal glucosuria].Rev Med Suisse. 2013 Mar 20;9(378):636-40. Rev Med Suisse. 2013. PMID: 23547366 French.
-
Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.Clin J Am Soc Nephrol. 2010 Jan;5(1):133-41. doi: 10.2215/CJN.04010609. Epub 2009 Nov 5. Clin J Am Soc Nephrol. 2010. PMID: 19965550 Review.
-
Glucose control by the kidney: an emerging target in diabetes.Am J Kidney Dis. 2009 May;53(5):875-83. doi: 10.1053/j.ajkd.2008.12.031. Epub 2009 Mar 26. Am J Kidney Dis. 2009. PMID: 19324482 Review.
Cited by
-
The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study.J Clin Med Res. 2017 May;9(5):403-409. doi: 10.14740/jocmr2806w. Epub 2017 Apr 1. J Clin Med Res. 2017. PMID: 28392860 Free PMC article.
-
Use of systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans.Front Pharmacol. 2014 Dec 10;5:274. doi: 10.3389/fphar.2014.00274. eCollection 2014. Front Pharmacol. 2014. PMID: 25540623 Free PMC article.
-
High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model.Biosci Rep. 2021 Jun 25;41(6):BSR20203947. doi: 10.1042/BSR20203947. Biosci Rep. 2021. PMID: 34003249 Free PMC article.
-
SLC5A2 mutations, including two novel mutations, responsible for renal glucosuria in Chinese families.BMC Nephrol. 2020 Feb 28;21(1):69. doi: 10.1186/s12882-020-01725-9. BMC Nephrol. 2020. PMID: 32111189 Free PMC article.
-
Salt-Losing Tubulopathies in Children: What's New, What's Controversial?J Am Soc Nephrol. 2018 Mar;29(3):727-739. doi: 10.1681/ASN.2017060600. Epub 2017 Dec 13. J Am Soc Nephrol. 2018. PMID: 29237739 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
